Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States

► We estimated the annual direct medical costs attributable to HPV in the USA. ► The overall annual direct medical cost burden was estimated to be $8.0 billion. ► Most of this cost was for cervical cancer screening and follow-up ($6.6 billion).